Back to Search
Start Over
Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant‐ineligible Multiple Myeloma Patients.
- Source :
- HemaSphere; Feb2023, Vol. 7 Issue 2, pe829-N.PAG, 1p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 7
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- 175251757
- Full Text :
- https://doi.org/10.1097/HS9.0000000000000829